29. Curent status of outpatient management of heart failure patients at Hanoi Medical University Hospital
Main Article Content
Abstract
A prospective cross-sectional study was conducted on 85 patients admitted for acute heart failure at Hanoi Medical University Hospital from June 1, 2023, to November 30, 2023. After stabilization and discharge, the patients were followed up for six months to evaluate the frequency of follow-up adherence and changes in left ventricular ejection fraction (LVEF) and proBNP levels among those with complete follow-up, as well as major cardiovascular events. The study found that only a small proportion (36%) of patients completed the full follow-up (all three visits) at Hanoi Medical University Hospital. Among the patients with complete follow-up, there was a marked improvement in cardiac function, with a 12% increase in LVEF and a 45% reduction in blood proBNP levels compared to admission. However, the overall incidence of major cardiovascular events (including death and readmission) remained high at 21%.
Article Details
Keywords
Acute heart failure, outpatient management of heart failure patients, left ventricular ejection fraction
References
2. Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145:e876–e894. doi: 10.1161/CIR.0000000000001062.
3. Ponikowski P, Voors AA, Stefan D Anker, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016; 18(8): 891-975. doi: 10.1002/ejhf.592.
4. Amy Groenewegen, Frans H. Rutten, Arend Mosterd, et al. Epidemiology of heart failure. European Journal of Heart Failure. 2020; 1342-1356. https://doi.org/10.1002/ejhf.1858.
5. World health organization. Bệnh tim mạch (CVD) ở Việt Nam. https://www.who.int/vietnam/vi/health-topics/cardiovascular-disease/cardiovascular-disease. 2016.
6. Phan Đình Phong, Phạm Thị Mai Hương, Đặng Việt Phong, Nguyễn Ngọc Quang. Thực trạng sử dụng các nhóm thuốc nền tảng trong điều trị suy tim mạn tính có phân suất tống máu giảm tại khoa khám bệnh - Bệnh viện Bạch Mai. Tạp Chí Y học Việt Nam. 2024;535(1B). https://doi.org/10.51298/vmj.v535i1B.8431.
7. Nga Vu Quynh, Thinh Do Duc, Hoa Tran Thanh. Adherence to GDMT treatment for heart failure out-patients – single center registry. Tạp chí Phẫu thuật Tim mạch và Lồng ngực Việt Nam. 2023; 42, 32-42. https://doi.org/10.47972/vjcts.v42i.899
8. Michael R Zile , Brian L Claggett , Margaret F Prescott , et al. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure. J Am Coll Cardiol. 2016; 68(22):2425-2436. https://doi.org/10.1016/j.jacc.2016.09.931
9. Tromp J, Ouwerkerk W, Van Veldhuisen DJ, et al. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2021;10(2):73-84. https://doi.org/10.1016/j.jchf.2021.09.004.
10. Donkor A, Suzanna Hardman, Marion Standing, et al. National Heart Failure Audit 2016. National Institute for Cardiovascular Outcomes Research (NICOR). 2016. https://www.hqip.org.uk/wp-content/uploads/2018/02/national-heart-failure-audit-report-april-2015-march-2016.pdf.